Developing a novel risk-scoring system for predicting relapse in patients with ulcerative colitis: A prospective cohort study

被引:0
|
作者
Hosseini, Seyed Vahid [1 ]
Safarpour, Ali Reza [2 ]
Taghavi, Seyed Alireza [2 ]
机构
[1] Shiraz Univ Med Sci, Faghihi Hosp, Colorectal Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Namazi Hosp, Gastroenterohepatol Res Ctr, Shiraz, Iran
关键词
Ulcerative Colitis; Relapse; Cohort Study; Prediction; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; FECAL CALPROTECTIN; MARKER; PARAMETERS; THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Ulcerative Colitis (UC) follows a natural clinical course of relapses and remissions. The aim of this study was to construct a risk-scoring formula in order to enable predicting relapses in patients with UC. Methods: From October 2012 to October 2013, 157 patients from Shiraz, southern Iran who were diagnosed with UC and in remission were enrolled. At 3-month intervals, multiple risk factors of hemoglobin, complete blood counts, serum iron and albumin, erythrocyte sedimentation rate, and faecal calprotectin levels, sex, age, cigarette smoking, positive family history of inflammatory bowel diseases, past history of appendectomy, extra-intestinal accompanying diseases, extent of disease at the beginning of study, number of previous relapses, duration of disease and duration of remission before the study were assessed. Univariate and multivariate logistic regression were applied to fit the final model. The new risk-scoring system accuracy was assessed using receiver-operating-characteristics (ROC) curve analysis. Results: Seventy four patients (48.1%) experienced a relapse. Multivariate analysis revealed that relapses could significantly be predicted by the level of fecal calprotectin (OR=8.1), age (OR=9.2), the Seo activity index (OR=52.7), and the number of previous relapses (OR=4.2). The risk scoring formula was developed using the regression coefficient values of the aforementioned variables. Conclusion: Four predictor variables were significant in the final model and were used in our risk-scoring formula. It is recommended that patients who achieve high scores are diligently observed, treated, and followed up.
引用
收藏
页码:1511 / 1516
页数:6
相关论文
共 50 条
  • [41] Evaluation of step up therapy in patients with early ulcerative colitis: a prospective cohort study
    Bossuyt, P.
    Baert, F.
    Coenegrachts, J-L
    De Vos, M.
    Dewit, O.
    Ferrante, M.
    Fontaine, F.
    Mana, F.
    Vandervoort, J.
    Moreels, T.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S253 - S254
  • [42] COLORECTAL-CANCER IN PATIENTS WITH ULCERATIVE-COLITIS - A PROSPECTIVE COHORT STUDY IN ITALY
    BIASCO, G
    BRANDI, G
    PAGANELLI, GM
    ROSSINI, FP
    SANTUCCI, R
    DIFEBO, G
    MIGLIOLI, M
    RISIO, M
    LABATE, AMM
    BARBARA, L
    CANCER, 1995, 75 (08) : 2045 - 2050
  • [43] A Quantified Risk-Scoring System for the Recurrence of Meningiomas: Results From a Retrospective Study of 392 Patients
    Zhu, Zhangzhang
    Wang, Chengde
    Xu, Jiadong
    Wang, Chunyong
    Xia, Lei
    Li, Qun
    Lu, Jianglong
    Cai, Lin
    Zheng, Weiming
    Su, Zhipeng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy
    Li, Yuqiang
    Tian, Mengxiang
    Zhou, Yuan
    Tan, Fengbo
    Liu, Wenxue
    Zhao, Lilan
    Perez, Daniel
    Song, Xiangping
    Wang, Dan
    Nitschke, Christine
    Pei, Qian
    Guengoer, Cenap
    JOURNAL OF CANCER, 2021, 12 (14): : 4433 - 4442
  • [46] Food Processing and Risk of Crohn's Disease and Ulcerative Colitis: A European Prospective Cohort Study
    Meyer, Antoine
    Dong, Catherine
    Casagrande, Corinne
    Chan, Simon S. M.
    Huybrechts, Inge
    Nicolas, Genevieve
    Rauber, Fernanda
    Levy, Renata Bertazzi
    Millett, Christopher
    Oldenburg, Bas
    Weiderpass, Elisabete
    Heath, Alicia K.
    Tong, Tammy Y. N.
    Tjonneland, Anne
    Kyro, Cecilie
    Kaaks, Rudolf
    Katzke, Verena A.
    Bergman, Manuela M.
    Palli, Domenico
    Masala, Giovanna
    Tumino, Rosario
    Sacerdote, Carlotta
    Colorado-Yohar, Sandra M.
    Sanchez, Maria-Jose
    Grip, Olof
    Lindgren, Stefan
    Luben, Robert
    Gunter, Marc J.
    Mahamat-Saleh, Yahya
    Boutron-Ruault, Marie-Christine
    Carbonnel, Franck
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (06) : 1607 - +
  • [47] Validation of a novel integral disease index for evaluating the grade of activity in Mexican patients with ulcerative colitis: A prospective cohort study
    Yamamoto-Furusho, J. K.
    Bozada-Gutierrez, K. E.
    Sanchez-Rodriguez, A.
    Bojalil-Romano, F.
    Barreto-Zuniga, R.
    Martinez-Benitez, B.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2019, 84 (03): : 317 - 325
  • [48] Gari-leo prospective study on anti-TNF therapy in ulcerative colitis relapse patients
    Kato, S.
    Kani, K.
    Ishibashi, A.
    Oka, M.
    Nagoshi, S.
    Yakabi, K.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S298 - S298
  • [49] The Impact of Cytomegalovirus Infection on Ulcerative Colitis Relapse: A Multicenter Retrospective Cohort Study
    Xiao, Linmei
    Ma, Jingjing
    Chen, Ruidong
    Chen, Jie
    Wang, Qiang
    Tang, Nana
    Zhao, Xiaojing
    Zhang, Hongjie
    Jiao, Chunhua
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 9059 - 9070
  • [50] Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn]
    Suresh, A. V. S.
    Varma, P. Pratap
    Sinha, Sudha
    Deepika, Satya
    Raman, Raghu
    Srinivasan, M.
    Mandapal, T.
    Reddy, C. Obula
    Anand, B. B.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2010, 6 (04) : 448 - 451